Jefferies Remains a Hold on Bayer (0P6S)
Jefferies analyst Chris Counihan maintained a Hold rating on Bayer today and set a price target of €25.00.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Counihan is an analyst with an average return of -2.2% and a 50.00% success rate. Counihan covers the Basic Materials sector, focusing on stocks such as Givaudan SA, Evonik, and Symrise.
In addition to Jefferies, Bayer also received a Hold from UBS’s Matthew Weston in a report issued on February 25. However, today, Barclays maintained a Buy rating on Bayer (LSE: 0P6S).
The company has a one-year high of €49.78 and a one-year low of €18.38. Currently, Bayer has an average volume of 3.67M.
Read More on GB:0P6S:
Disclaimer & DisclosureReport an Issue
- Bayer reports Q4 core EPS EUR 0.62 vs. EUR 1.05 last year
- Bayer sees FY26 sales EUR 45B-EUR 47B
- Bayer: Dose for expansion in PAnTHa study successfully identified
- Bayer reports final results from Phase III PEACE-3 trial of XOFIGO
- Law firms urge judge to delay review of proposed Bayer settlement, Reuters says
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.